Fundamental Analysis of NOVOCURE LTD(NASDAQ:NVCR) stock

Fundamental Rating

Taking everything into account, NVCR scores 2 out of 10 in our fundamental rating. NVCR was compared to 196 industry peers in the Health Care Equipment & Supplies industry. NVCR may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, NVCR is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

NVCR had negative earnings in the past year.

NVCR had a negative operating cash flow in the past year.

NVCR had negative earnings in 4 of the past 5 years.

NVCR had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

NVCR has a Return On Assets (-18.07%) which is comparable to the rest of the industry.

NVCR has a Return On Equity of -57.13%. This is comparable to the rest of the industry: NVCR outperforms 44.90% of its industry peers.

		Industry Rank	Sector Rank
ROA	-18.07%
ROE	-57.13%
ROIC	N/A

ROA(3y)-10.32%

ROA(5y)-6.11%

ROE(3y)-30.77%

ROE(5y)-18.29%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

NVCR has a better Gross Margin (74.80%) than 85.20% of its industry peers.

In the last couple of years the Gross Margin of NVCR has grown nicely.

The Profit Margin and Operating Margin are not available for NVCR so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	74.8%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.57%

GM growth 5Y2.01%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

NVCR does not have a ROIC to compare to the WACC, probably because it is not profitable.

NVCR has more shares outstanding than it did 1 year ago.

NVCR has more shares outstanding than it did 5 years ago.

NVCR has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.45, we must say that NVCR is in the distress zone and has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 0.45, NVCR is in line with its industry, outperforming 49.49% of the companies in the same industry.

NVCR has a Debt/Equity ratio of 1.57. This is a high value indicating a heavy dependency on external financing.

The Debt to Equity ratio of NVCR (1.57) is worse than 84.69% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.57
Debt/FCF	N/A
Altman-Z	0.45

ROIC/WACCN/A

WACC8.13%

2.3 Liquidity

NVCR has a Current Ratio of 5.78. This indicates that NVCR is financially healthy and has no problem in meeting its short term obligations.

The Current ratio of NVCR (5.78) is better than 77.55% of its industry peers.

A Quick Ratio of 5.56 indicates that NVCR has no problem at all paying its short term obligations.

NVCR's Quick ratio of 5.56 is amongst the best of the industry. NVCR outperforms 81.63% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	5.78
Quick Ratio	5.56

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for NVCR have decreased strongly by -121.59% in the last year.

NVCR shows a decrease in Revenue. In the last year, the revenue decreased by -5.28%.

NVCR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.47% yearly.

EPS 1Y (TTM)-121.59%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q-25%

Revenue 1Y (TTM)-5.28%

Revenue growth 3Y1%

Revenue growth 5Y15.47%

Revenue growth Q2Q4.19%

3.2 Future

NVCR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.58% yearly.

NVCR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.31% yearly.

EPS Next Y8.09%

EPS Next 2Y2.04%

EPS Next 3Y1.35%

EPS Next 5Y5.58%

Revenue Next Year6.2%

Revenue Next 2Y7.03%

Revenue Next 3Y8.97%

Revenue Next 5Y10.31%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NVCR. In the last year negative earnings were reported.

Also next year NVCR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y2.04%

EPS Next 3Y1.35%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for NVCR!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NOVOCURE LTD

NASDAQ:NVCR (4/18/2024, 7:11:26 PM)

After market: 12.04 -0.01 (-0.08%)

12.05

0 (0%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap1.29B

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-18.07%
ROE	-57.13%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	74.8%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.44

Health

		Industry Rank	Sector Rank
Debt/Equity	1.57
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	5.78
Quick Ratio	5.56
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-121.59%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y8.09%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-5.28%

Revenue growth 3Y1%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

NOVOCURE LTD (NVCR)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens